International Patent: AZETUKALNER FOR USE IN THE TREATMENT OF DEPRESSION, ANHEDONIA OR A SEIZURE DISORDER SUCH AS EPILEPSY IN PEDIATRIC SUBJECTS

GENEVA, July 1 -- XENON PHARMACEUTICALS INC. filed a patent application (US2025/016769) for “AZETUKALNER FOR USE IN THE TREATMENT OF DEPRESSION, ANHEDONIA OR A SEIZURE DISORDER SUCH AS EPILEPSY IN PEDIATRIC SUBJECTS”. With publication no. WO/2025/179128, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: A61K 31/472

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....